CK Life Sciences International Holdings (FRA:LSI) ROCE % : 4.45% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CK Life Sciences International Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 4.45%.

CK Life Sciences International Holdings ROCE % Historical Data

The historical data trend for CK Life Sciences International Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings ROCE % Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

4.88

2.63

3.36

4.53

4.71

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															3.09	3.43	5.07	5.11	4.45

CK Life Sciences International Holdings ROCE % Calculation

CK Life Sciences International Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	45.911	/	( ( (1366.124 - 492.586)	+	(1320.632 - 246.641) )	/ 2 )
	=	45.911	/	( (873.538	+	1073.991)	/ 2 )
	=	45.911	/	973.7645
	=	4.71 %

CK Life Sciences International Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	45.198	/	( ( (1301.99 - 342.668)	+	(1320.632 - 246.641) )	/ 2 )
	=	45.198	/	( ( 959.322	+	1073.991 )	/ 2 )
	=	45.198	/	1016.6565
	=	4.45 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

CK Life Sciences International Holdings (FRA:LSI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

CK Life Sciences International Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (FRA:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (FRA:LSI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

00775:Hong Kong

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.